KOSPIChemicals134380

Miwon Chemicals

₩11,840▼ 0.08%2026-11-18 close
Market Cap
₩260.4B
Turnover
₩100M
Volume
10K
Shares out.
22M
PER
4.8×
PBR
1.3×
EPS
₩2,476
Dividend Yield
—

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Prices as of the 2026-11-18 close

01

Report overview

Quarterly Profit Rebounds, Annual Earnings Flat

Miwon Chemicals' quarterly sales and operating profit rose sharply through 2026, but net profit attributable to controlling shareholders fell in 2025. The 2026 annual report is the next checkpoint for whether the rebound holds.

  1. 1

    Third-quarter 2026 sales were KRW 115.3 billion, up 58.3% year on year, and operating profit was KRW 22.9 billion, up 160.6%.

  2. 2

    Annual sales reached KRW 284.5 billion in 2025 and rose for a second straight year, while net profit attributable to controlling shareholders fell 8.2% to KRW 24.7 billion.

  3. 3

    Operating cash flow fell to KRW 20.7 billion in 2025 from KRW 38.2 billion in 2024.

  4. 4

    Surfactant exports accounted for 70.35% of surfactant sales in the 2025 fiscal year, and the company held a 70% share of refined sulfuric acid as of June 2026.

  5. 5

    The debt ratio eased to 12.8% at the end of 2025 from 15.3% in 2024, and total equity stood at KRW 173.6 billion.

02

Business structure

Miwon Chemicals was spun off from Miwon Commercial in 2011 and listed on the KOSPI the same year. It produces and supplies sulfuric acid and sulfur products, rubber additives, and raw materials for household goods and detergents, with surfactants and sulfur and sulfuric acid products as its core lines.

Surfactant exports made up 70.35% of surfactant sales and sulfur and sulfuric acid exports made up 65.41% of their sales in the 2025 fiscal year, according to Wisereport, showing a heavy reliance on overseas sales.

As of June 2026, the company held reported market shares of 70% in refined sulfuric acid, 60% in powdered sulfur, and 20% in sulfonic acid within surfactants. Most of its products are raw materials sold to manufacturers of detergents, rubber and household goods, so its customer base is business to business.

R&D spending was KRW 1.341 billion in 2025, or 0.47% of sales. The company credited the first-half 2026 improvement to new applications and overseas expansion for surfactants and to new markets for sulfur and sulfuric acid products.

Affiliate Miwon Specialty Chemical is a separate listed company focused on UV and EB curable resins, so its business mix differs. As of October 14, 2026, related parties of the largest shareholder held 55.46% of shares and treasury shares accounted for 11.85%.

Unlike large petrochemical groups such as LG Chem and Lotte Chemical, the company is a small-to-mid-sized player concentrated on a few product lines.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩72.8B₩8.8B12.1%
2025Q4₩77.3B₩5.1B6.6%
2026Q1₩86.4B₩9B10.4%
2026Q2₩105.4B₩24.3B23.1%
2026Q3₩115.3B₩22.9B19.9%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩235.2B₩19B₩16.3B8.1%12.3%11.4%
2023₩232.6B₩24.9B₩21.8B10.7%15.1%14.0%
2024₩256.1B₩28.6B₩26.9B11.2%16.6%15.3%
2025₩284.5B₩29.2B₩24.7B10.2%14.2%12.8%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-10

04

Earnings analysis

Annual sales fell from KRW 235.2 billion in 2022 to KRW 232.6 billion in 2023, a 1.1% decline, then rose to KRW 256.1 billion in 2024 (up 10.1%) and KRW 284.5 billion in 2025 (up 11.1%), growing for two straight years from 2024 through 2025.

Across 2022 to 2025, 2025 was the largest year for sales and 2023 the smallest.

Operating profit went from KRW 19 billion in 2022 to KRW 24.9 billion in 2023 (up 31.2%), KRW 28.6 billion in 2024 (up 14.9%) and KRW 29.2 billion in 2025 (up 1.8%), rising three straight years from 2023 through 2025, though growth slowed to a single digit in 2025.

The operating margin rose from 8.1% in 2022 to 11.2% in 2024 before easing to 10.2% in 2025. Net profit attributable to controlling shareholders climbed from KRW 16.3 billion in 2022 to KRW 26.9 billion in 2024 (up 23.5% year on year) before falling 8.2% to KRW 24.7 billion in 2025.

The gap between a slight rise in 2025 operating profit and the drop in attributable net profit is best read as reflecting changes in non-operating items and tax expense.

Operating cash flow rose from KRW 28.5 billion in 2022 to KRW 38.2 billion in 2024 and then fell to KRW 20.7 billion in 2025, so cash generation weakened relative to profit.

Quarterly results bottomed in the fourth quarter of 2025, when sales of KRW 77.3 billion (up 6.2% from the prior quarter) came with operating profit of KRW 5.1 billion (down 42.1%).

Operating profit then recovered to KRW 9 billion in the first quarter of 2026, KRW 24.3 billion in the second and KRW 22.9 billion in the third, while sales rose for four straight quarters from the fourth quarter of 2025 through the third quarter of 2026.

According to Wisereport, separate-basis sales in the first half of 2026 rose 42.8% and operating profit rose 118.8%. The second-quarter operating profit of KRW 24.3 billion is the largest of the last five quarters, and whether one-off items contributed should be checked in that quarter's report notes.

05

Industry analysis

The company's end markets are sulfur and sulfuric acid intermediates used in detergents (surfactants), rubber processing (rubber additives), and metal surface treatment and electronics processes.

Demand for intermediates moves with the production cycle of downstream industries and with raw material prices, so quarterly profit is sensitive to those flows.

In the 2025 fiscal year, surfactants were 29.65% domestic and 70.35% export, and sulfur and sulfuric acid products were 34.59% domestic and 65.41% export, so sales lean heavily on overseas customers. Higher overseas demand adds to profit, but it also exposes results to exchange rates and local economic swings.

As of June 2026, shares of 70% in refined sulfuric acid and 60% in powdered sulfur point to strong positions in those product lines. Within surfactants, sulfonic acid's 20% share shows that positions vary by product.

Within the chemical sector, Miwon Chemicals differs in scale and product mix from large petrochemical and materials groups such as LG Chem, Lotte Chemical and Kumho Petro Chemical.

Specialty chemical peers listed in Korea include ISU Specialty Chemical, Foosung and LOTTE Fine Chemical, though each has a different product mix. The most direct signals of where the cycle stands are next-quarter order volumes and raw material price trends.

06

Outlook

Full-year 2026 results will be finalized in the 2026 annual report, which is expected in early March 2027 based on the prior year's annual report being filed on March 1, 2026.

The company cited new applications and overseas expansion for surfactants, and new markets for sulfur and sulfuric acid products, as drivers of growth. Whether these three drivers persist will show up in whether sales growth holds after the third quarter of 2026.

Third-quarter operating profit fell 5.8% from the prior quarter to KRW 22.9 billion, so whether profit stays at its elevated level after the second-quarter jump is the next checkpoint.

The first-quarter 2027 report is expected around early May 2027, based on the first-quarter 2026 results having been released on May 8, 2026. As of October 14, 2026, treasury shares stood at 11.85%, and their cancellation or use will be shown in future disclosures.

A governance report from September 2026 discussed the shareholding structure of the Miwon family and the possibility of a split of Miwon Chemicals. Whether split discussions turn into formal disclosures is a separate item to track.

07

Valuation

PER
4.8×
PBR
1.3×
ROE
25.6%
EPS
₩2,476
BPS
₩9,361
Dividend per share
—

Price-to-book reflects the market value of the company relative to its book equity, and the current market capitalization sits at a premium to total equity of KRW 173.6 billion at the end of 2025.

Because quarterly profit has recovered in 2026, earnings-based multiples read differently than they would on 2025 annual profit alone. Using the last four quarters of net profit attributable to controlling shareholders, which total KRW 48.2 billion, the multiple is highly sensitive to quarterly swings.

The operating margin was 10.2% in 2025, below 11.2% in 2024, so the share of sales converted into operating profit narrowed slightly. Comparing the current multiple with the company's past trading range requires period-specific share price data.

Because multiples move with both price and earnings, reading them accurately requires looking at the pace of earnings recovery alongside the share price.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-10

08

Bull factors

Quarterly profit recovery

Operating profit recovered from KRW 5.1 billion in the fourth quarter of 2025 to KRW 9 billion in the first quarter of 2026, KRW 24.3 billion in the second and KRW 22.9 billion in the third. Third-quarter sales of KRW 115.3 billion rose 58.3% year on year, so volume growth and profit recovery arrived together. Wisereport's figures show separate-basis operating profit in the first half of 2026 rose 118.8%.

Overseas sales and product-level shares

Surfactant exports made up 70.35% of surfactant sales in the 2025 fiscal year, and sulfur and sulfuric acid exports made up 65.41%. As of June 2026, reported shares were 70% in refined sulfuric acid and 60% in powdered sulfur. In this structure, rising overseas demand translates directly into higher sales.

Lower debt and a solid equity base

Total equity was KRW 173.6 billion at the end of 2025, and total liabilities were KRW 22.2 billion. The debt ratio fell from 15.3% in 2024 to 12.8% in 2025. With a lighter debt burden, the company has relatively more room for facility and R&D spending.

09

Bear factors

Slowing annual profit growth

Operating profit reached KRW 29.2 billion in 2025, up only 1.8%, a sharp slowdown in growth. Net profit attributable to controlling shareholders fell 8.2% to KRW 24.7 billion, giving up the KRW 26.9 billion peak of 2024. Changes in non-operating items and taxes appear to have weighed on the bottom line.

Weaker cash generation

Operating cash flow fell from KRW 38.2 billion in 2024 to KRW 20.7 billion in 2025, even as operating profit edged up. Whether the drop came from working capital or from capital spending can be checked in the cash flow statement detail of the annual report.

Quarterly volatility and one-off risk

Quarterly operating profit swung from KRW 5.1 billion in the fourth quarter of 2025 to KRW 24.3 billion in the second quarter of 2026, a large spread. Third-quarter 2026 operating profit fell 5.8% from the prior quarter to KRW 22.9 billion. Whether one-off items were included in the second-quarter jump determines how durable the recovery is.

10

Risk factors

Governance and shareholder structure

In June 2026 the group of related parties of the largest shareholder changed from 33 to 40 persons, with the stake moving from 55.24% to 54.80%. Together with the treasury share position of 11.85% and media reports on governance changes, how shareholder value is distributed remains a variable.

Overseas demand and exchange rates

Surfactant exports at 70.35% and sulfur and sulfuric acid exports at 65.41% of their respective sales leave the company highly dependent on overseas demand. Changes in foreign customer demand and exchange rates therefore feed directly into sales and profit.

Raw materials and quarterly swings

If raw sulfur or sulfuric acid prices and downstream orders shift, quarterly profit can swing widely. The gap in operating profit between the fourth quarter of 2025 and the second quarter of 2026 illustrates this exposure.

11

What to watch next

  1. Early March 2027 (estimated)

    The 2026 annual report will show full-year sales, operating margin and operating cash flow. The 2025 operating margin of 10.2% and operating cash flow of KRW 20.7 billion are the comparison baselines.

  2. Early May 2027 (estimated)

    The first-quarter 2027 report will show whether operating profit holds near the KRW 24.3 billion of the second quarter of 2026, and whether the third-quarter decline of 5.8% becomes a trend.

  3. During 2027 (date not yet set)

    Disclosures on how the 11.85% treasury stake will be used and any changes in the largest shareholder's stake will be watched. Whether governance reports turn into formal filings and transactions is the checkpoint.

12

Overall view

Miwon Chemicals' 2025 annual results were mixed, with sales and operating profit up while net profit attributable to controlling shareholders and operating cash flow declined.

The fourth quarter of 2025 was the low point, and from the first through the third quarter of 2026 sales and operating profit rose together, with third-quarter sales up 58.3% and operating profit up 160.6% year on year.

The recovery rests on overseas sales of surfactants and sulfur and sulfuric acid products, and on high reported market shares in refined sulfuric acid and powdered sulfur.

On the balance sheet, the debt ratio fell to 12.8% at the end of 2025 and total equity reached KRW 173.6 billion, giving the company ample financial room. On the other side, the annual decline in net profit, weaker cash generation, and the question of whether the second-quarter jump included one-offs remain open.

On governance, related parties of the largest shareholder hold 55.46%, treasury shares stand at 11.85%, and media have raised the possibility of a split. With both strengths and weaknesses present, the 2026 annual report, where full-year operating margin and cash flow are confirmed, is the key turning point. This report does not give an investment opinion, rating or target price.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 15 more articles and sources
  1. comp.wisereport.co.kr
  2. comp.wisereport.co.kr
  3. jobkorea.co.kr
  4. vegannews.co.kr
  5. jasoseol.com
  6. news.bizwatch.co.kr
  7. moneypie.net
  8. jobplanet.co.kr
  9. kr.investing.com
  10. edaily.co.kr
  11. natlawreview.com
  12. kr.investing.com
  13. etoday.co.kr
  14. etoday.co.kr
  15. judal.co.kr

Report written 2026-11-11 · Data as of 2026-11-10

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis